Bony spur softening paste

Abstract

The invention relates to a bony spur softening paste which comprises raw materials in parts by weight: 15 parts of Chinese angelica, 15 parts of safflower, 25 parts of red paeony root, 15 parts of rhizoma drynariae, 35 parts of rheum officinale, 25 parts of szechuan lovage rhizome, 15 parts of jackinthepulpit tuber, 25 parts of radix aconiti preparata, 25 parts of prepared kusnezoff monkshood root, 20 parts of white mustard seed, 25 parts of Chinese wild ginger, 25 parts of tooth soap, 15 parts of notopterygium root, 15 parts of pubescent angelica root, 3 parts of mothball, 25 parts of Chinese yellow azalea, 25 parts of homalomena occulta, 15 parts of cortex Illicii, 25 parts of myrrh, 3 parts of borneol, 45 parts of piper wallichii, and 35 parts of kadsura pepper stem. The preparation method comprises the following steps: the components are processed according to the ancient processing in a way strictly controlling the quality; crushing, grinding and sieving by a 200-mesh basket together; taking raw medicinal powder 20 g, and adding honey to prepare a shape of the paste. The paste can not to be too dry, and is applied to an affected part externally, without flowing; the medicine is changed every three days, every 10 times are taken as a treatment course, and 2-3 treatment courses are required for few serious patients. According to the invention, the treatment course is short, the curative effect is obvious and side effect is avoided.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine, and in particular relates to a bone spur softening ointment. Background technique [0002] Osteoarthritis is a degenerative bone disease. It is a group of intractable diseases that often occur in middle-aged and elderly people, such as cervical spondylosis, lumbar spondylosis, hypertrophic arthritis, sciatica, etc. The older you are, the higher the incidence rate. Osteoarthritis has become one of the intractable diseases that affect the quality of life of middle-aged and elderly people. The treatment of osteoporosis in modern medicine includes surgical treatment and conservative drug treatment. Due to the high cost of surgery, the curative effect is difficult to guarantee, and the number of patients is old, weak and sick, which increases the risk of surgery, and most people are unwilling to accept it; existing drug treatment Osteoproliferative disease, one is to use internal medicine...

AI Technical Summary

Problems solved by technology

The treatment of osteoporosis in modern medicine includes surgical treatment and conservative drug treatment. Due to the high cost of surgery, the curative effect is difficult to guarantee, and the number of patients is old, weak and sick, which increases the risk of surgery, and most people are unwilling to accept it; existing drug treatment Osteoproliferative disease, one is to use internal medicine, when the medicine reaches the affected area, the effect of the medicine is very little, so the treatment process is slow and the curative effect is low, and the medicine will also cause damage to the liver, kidney, waist, and the other is to use external medicine, now clinical Most of the externally applied drugs are hormones and indomethacin, which can only temporarily relieve pain, treat the symptoms but not the root cause, and fail to repair the damaged bone. The disease is prone to repeated attacks